{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"ehlers-danlos-syndrome-fibronectinemic-type","columns":[{"gene":"","key":"population-66d703156efdb75c9efa","label":"Ehlers-Danlos syndrome with platelet dysfunction from fibronectin abnormality","mondoId":"MONDO:0009158","onsetQualifier":null,"originColumnKey":"MONDO:0009158/OMIM:225310","originalViews":[{"key":"MONDO:0009158/OMIM:225310","label":"Ehlers-Danlos syndrome with platelet dysfunction from fibronectin abnormality","scopeLabel":"OMIM:225310","sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"recordKeys":["3b0dec243c49be31dffd21a9b88f061fc6c03a22db04564dd27811b373f2c33e","4f0498d1430a754718f50f0c065ef99c8ab867fb82da75bb421c6005692c37a5","55052a883d86be568d6e19a7591697ed89d44e24eade892e9151c6afd2034fd6","7a5c7318f9ca85d3b980e0e672443d9cc8e2cd059d0a4b5bb8a62f4a883b539a","8b3591397dc362e5e466f7c16f848189ddf93bd4823443657b4018d01ce53791","c77b785be335c43385537587b36ac90be5f6f8d5f2d8fbd90ed2885aebfc7b2c","cacc4c51ce0a58bea21c896ab9dacfb608fcbbb8e274878e147463dd398e384d","e75b8bda51b74440615ec53ee474f6d6e8d8a7dbcd741f35d4289bc35b915fba"],"recordQualifiers":{},"scopeLabel":"OMIM:225310","sourceIds":["OMIM:225310"],"sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-66d703156efdb75c9efa"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0000987","HP:0000978","HP:0000974","HP:0001382","HP:0001634","HP:0000967","HP:0001065"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":8,"sourceGroups":{"omim":8}},"features":[{"hpoId":"HP:0000987","label":"Atypical scarring of skin","primary":true},{"hpoId":"HP:0000978","label":"Bruising susceptibility","primary":true},{"hpoId":"HP:0000974","label":"Hyperextensible skin","primary":true},{"hpoId":"HP:0001382","label":"Joint hypermobility","primary":true},{"hpoId":"HP:0001634","label":"Mitral valve prolapse","primary":true},{"hpoId":"HP:0000967","label":"Petechiae","primary":true},{"hpoId":"HP:0001065","label":"Striae distensae","primary":true},{"hpoId":"HP:0000963","label":"Thin skin","primary":false}],"ledeHtml":"Ehlers-Danlos syndromes (EDS) form a heterogeneous group of inherited connective tissue disorders characterized by variable joint hypermobility and cutaneous hyperextensibility. Type X is distinguished by platelet dysfunction associated with a fibronectin abnormality. Type X EDS has been described in only one family so far. Age of onset is about 13-25 years. Transmission is autosomal recessive.","mondoId":"MONDO:0009158","node":{"canonicalSlug":"ehlers-danlos-syndrome-fibronectinemic-type","comparisons":[{"documentSha256":"ecdb1bcb8beec0e608256c9c2d1ab336fc0facc7c2a14e116d12a5922bf84ac2","key":"expanded-ehlers-danlos","kind":"expanded","label":"Ehlers-Danlos syndrome","memberIds":["MONDO:0002014","MONDO:0007522","MONDO:0007523","MONDO:0007524","MONDO:0007525","MONDO:0007526","MONDO:0007527","MONDO:0007528","MONDO:0007842","MONDO:0009158","MONDO:0009159","MONDO:0009161","MONDO:0009242","MONDO:0010586","MONDO:0011142","MONDO:0011670","MONDO:0012114","MONDO:0012873","MONDO:0013605","MONDO:0013800","MONDO:0014139","MONDO:0014236","MONDO:0014954","MONDO:0016002","MONDO:0016469","MONDO:0016470","MONDO:0017314","MONDO:0019567","MONDO:0019568","MONDO:0020066","MONDO:0020521","MONDO:0020681","MONDO:0020682","MONDO:0020684","MONDO:0024543","MONDO:0030854","MONDO:0030855","MONDO:0034022","MONDO:0040501","MONDO:0054813","MONDO:0100599","MONDO:0100606","MONDO:0971044","MONDO:7770749"],"mondoId":"MONDO:0020066","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/node-comparison-ecdb1bcb8beec0e60825.ecdb1bcb8beec0e608256c9c2d1ab336fc0facc7c2a14e116d12a5922bf84ac2.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"definition-only","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"Ehlers-Danlos syndrome, fibronectinemic type","originalSourceId":null,"paragraphs":["Ehlers-Danlos syndromes (EDS) form a heterogeneous group of inherited connective tissue disorders characterized by variable joint hypermobility and cutaneous hyperextensibility. Type X is distinguished by platelet dysfunction associated with a fibronectin abnormality. Type X EDS has been described in only one family so far. Age of onset is about 13-25 years. Transmission is autosomal recessive."],"rawAttribution":"MONDO:0009158","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-25T03:40:15Z","upstream":"MONDO:0009158","url":"https://rarediseases.info.nih.gov/diseases/8508"},"ownColumnKeys":["population-66d703156efdb75c9efa"],"publication":"published","relationships":[{"kind":"parent","label":"inherited bleeding disorder, platelet-type","mondoId":"MONDO:0000009","slug":null},{"kind":"parent","label":"Ehlers-Danlos syndrome","mondoId":"MONDO:0020066","slug":"ehlers-danlos"},{"kind":"parent","label":"inherited blood coagulation disorder","mondoId":"MONDO:0021181","slug":"inherited-blood-coagulation-disorder"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"pending"},"records":[{"frequencyKind":"reported","key":"3b0dec243c49be31dffd21a9b88f061fc6c03a22db04564dd27811b373f2c33e","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:225310","disease_name":"Ehlers-Danlos syndrome with platelet dysfunction from fibronectin abnormality","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0000987","is_excluded":false,"label":"Atypical scarring of skin","onset_id":null,"reference":"OMIM:225310","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"4f0498d1430a754718f50f0c065ef99c8ab867fb82da75bb421c6005692c37a5","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:225310","disease_name":"Ehlers-Danlos syndrome with platelet dysfunction from fibronectin abnormality","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001382","is_excluded":false,"label":"Joint hypermobility","onset_id":null,"reference":"OMIM:225310","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"55052a883d86be568d6e19a7591697ed89d44e24eade892e9151c6afd2034fd6","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"OMIM:225310","disease_name":"Ehlers-Danlos syndrome with platelet dysfunction from fibronectin abnormality","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001634","is_excluded":false,"label":"Mitral valve prolapse","onset_id":null,"reference":"OMIM:225310","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"7a5c7318f9ca85d3b980e0e672443d9cc8e2cd059d0a4b5bb8a62f4a883b539a","raw":{"aspect":"P","body_system":"skin","disease_id":"OMIM:225310","disease_name":"Ehlers-Danlos syndrome with platelet dysfunction from fibronectin abnormality","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001065","is_excluded":false,"label":"Striae distensae","onset_id":null,"reference":"OMIM:225310","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"8b3591397dc362e5e466f7c16f848189ddf93bd4823443657b4018d01ce53791","raw":{"aspect":"P","body_system":"skin","disease_id":"OMIM:225310","disease_name":"Ehlers-Danlos syndrome with platelet dysfunction from fibronectin abnormality","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0000974","is_excluded":false,"label":"Hyperextensible skin","onset_id":null,"reference":"OMIM:225310","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"c77b785be335c43385537587b36ac90be5f6f8d5f2d8fbd90ed2885aebfc7b2c","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:225310","disease_name":"Ehlers-Danlos syndrome with platelet dysfunction from fibronectin abnormality","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0000978","is_excluded":false,"label":"Bruising susceptibility","onset_id":null,"reference":"OMIM:225310","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"cacc4c51ce0a58bea21c896ab9dacfb608fcbbb8e274878e147463dd398e384d","raw":{"aspect":"P","body_system":"skin","disease_id":"OMIM:225310","disease_name":"Ehlers-Danlos syndrome with platelet dysfunction from fibronectin abnormality","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0000963","is_excluded":false,"label":"Thin skin","onset_id":null,"reference":"OMIM:225310","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"e75b8bda51b74440615ec53ee474f6d6e8d8a7dbcd741f35d4289bc35b915fba","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:225310","disease_name":"Ehlers-Danlos syndrome with platelet dysfunction from fibronectin abnormality","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0000967","is_excluded":false,"label":"Petechiae","onset_id":null,"reference":"OMIM:225310","source_release":"2026-06-23"},"sourceGroups":["omim"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/8508\" rel=\"noreferrer\">GARD</a></p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0009158\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>definition-only</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>MONDO:0009158</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>Ehlers-Danlos syndromes (EDS) form a heterogeneous group of inherited connective tissue disorders characterized by variable joint hypermobility and cutaneous hyperextensibility. Type X is distinguished by platelet dysfunction associated with a fibronectin abnormality. Type X EDS has been described in only one family so far. Age of onset is about 13-25 years. Transmission is autosomal recessive.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/8508\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Brief description"}],"sharedSources":[],"slug":"ehlers-danlos-syndrome-fibronectinemic-type","sourceDocuments":[{"name":"GARD: Ehlers-Danlos syndrome, fibronectinemic type","reviewed":null,"source_release":"2026-10-25T03:40:15Z","url":"https://rarediseases.info.nih.gov/diseases/8508"},{"name":"MONDO: Ehlers-Danlos syndrome, fibronectinemic type","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0009158"}],"sourceNote":"","synonyms":["EDS X","EDS10 (formerly)","Ehlers-Danlos syndrome type 10","Ehlers-Danlos syndrome type 10 (formerly)","Ehlers-Danlos syndrome with platelet dysfunction from fibronectin abnormality","Ehlers-Danlos syndrome, fibronectin-deficient","Ehlers-Danlos syndrome, type X (formerly)"],"takeawayHtml":"","title":"Ehlers-Danlos syndrome, fibronectinemic type"},"schemaVersion":1}
